학술논문
Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck
Document Type
Article
Author
Source
In Annals of Oncology April 2018 29(4):998-1003
Subject
Language
ISSN
0923-7534